Author(s): Boutrouille A, BakkaliKassimi L, Crucire C, Pavio N
Abstract Share this page
Abstract Accumulating evidence suggests that hepatitis E virus (HEV) infection is an emerging disease in regions where HEV is nonendemic. In France, the prevalence of anti-HEV antibodies in the general population has never been studied. Using blood donors' samples, we have found a prevalence of 3.20\%, which is similar to that of other industrialized countries.
This article was published in J Clin Microbiol
and referenced in Journal of Antivirals & Antiretrovirals